Avatex Corp.
6422 Riverview Lane
Dallas,
TX 75248-2838
United States - Map
| Index Membership: | N/A | | Sector: | N/A | | Industry: | N/A | | Full Time Employees: | 21 |
|
| Avatex Corporation's assets were liquidated and the court signed the final decree on 6/30/2004. Avatex Corporation operates as a holding company that owns interests in other corporations and partnerships. The company, through Chemlink Acquisition Company, LLC, controls 50% interest in Chemlink Laboratories, LLC, which principally develops, manufactures, and distributes proprietary effervescent tablet and granule formulations for use in cleaning, disinfecting, and sterilization applications. In addition to pursuing opportunities in the dental and medical markets, Chemlink has developed a patentable formulation and process for the manufacture of effervescent tablets, granules, and powders. The company owns approximately 13.5% interest in Presby Corp., a privately held company that has developed a surgical technique called the Surgical Reversal of Presbyopia, which uses a patented medical device, the Scleral Expansion Band, to treat presbyopia. Avatex owns the equivalent of an approximate 14.5% interest in iLife Systems, Inc., a privately held corporation. iLife owns certain patents issued or pending, which provide for electrode-free methods for detecting and analyzing breathing, heart rate, and body motions, as well as methods for microwatt wireless transmission, for digital data recording, and for electrode-free, infrasound-based detection and intervention. In addition, it owns interest in Phar-Mor, Inc., which operates a chain of discount retail drugstores. Avatex was founded in 1929. |
|
| Key Statistics |
| |
No officers available for AVATQ.PK |
1.29% Nasdaq 
Profile
